TraumaCure

TraumaCure is a medical technology company specializing in the development and commercialization of advanced hemostatic solutions for emergency, clinical, and consumer use. The company's core technology is m.doc (Micro-Dispersed Oxidized Cellulose), a proprietary, pH-neutral, and biodegradable powder derived from alpha-cellulose that rapidly stops bleeding by forming a gel-like layer upon contact with blood. This technology is utilized in the BleedArrest product line, which includes powders, bandages, and swabs designed for rapid response to trauma and minor injuries. TraumaCure's products are particularly noted for being non-exothermic and effective even in patients using anticoagulant medications like aspirin or warfarin. The company targets a wide range of applications, from military and first responder use to sports medicine and home first aid.